company update, page-4

I agree Strauss that why I bought in ..again after the losses - . thanks for the charts as well.
no doubt some games will be played like on all the other small caps eg SUD AHZ but what makes this really exciting is that most of the work is done and its not far off as you say.

Its still a spec stock but having fallen over a while back I reckon its been ignored by a lot of people and IMO DYOR is good value and may well surprise. I contacted them a little while back and got a really good feeling for the fact that they are responsive and open to shareholders queries.

Redant may I suggest you contact them - no reason why they wont answer your queries - from memory when they were looking at options for funding the reason they did not go down the traditional path was because the value of the antibiotics wasn't being recognised.